Dipsikha Biswas

Dr. Dipsikha Biswas

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200 Copenhagen, Denmark
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Dipsikha BiswasDipsikha Biswas
Dipsikha Biswas
LDLuke Duffley
Luke Duffley
Dr. Thomas PulinilkunnilDr. Thomas Pulinilkunnil
Dr. Thomas Pulinilkunnil
Beyond their contribution as fundamental building blocks of life, branched‐chain amino acids (BCAAs) play a critical role in physiologic and pathologic processes. Importantly, BCAAs are associated with insulin resistance, obesity, cardiovascular disease, and genetic disorders. However, several metabolome‐wide studies in recent years could not attribute alterations in systemic BCAAs as the sole driver of endocrine perturbations, suggesting that a snapshot of global BCAA changes does not always reveal the underlying modifications. Because enzymes catabolizing BCAAs have a unique distribution, it is plausible that the tissue‐specific roles of BCAA‐catabolic enzymes could precipitate changes in systemic BCAA levels, flux, and action. We review the genetic and pharmacological approaches dissecting the role of BCAA‐catabolic enzyme dysfunctions. We summarized emerging evidence on BCAA metabolic intermediates, tissue specificity of BCAA‐catabolizing enzymes, and crosstalk between different metabolites in driving metabolic maladaptation in health and pathology. This review substantiates the understanding that tissue‐specific dysfunction of the BCAA‐catabolic enzymes and accumulating intermediary metabolites could act as better surrogates of metabolic imbalances, highlighting the biochemical communication among the nutrient triad of BCAAs, glucose, and fatty acid.—Biswas, D., Duffley, L., Pulinilkunnil, T. Role of branched‐chain amino acid–catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis. FASEB J. 33, 8711–8731 (2019). www.fasebj.org

1 November 2020 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
QKQutuba Karwi
Qutuba Karwi
Dipsikha BiswasDipsikha Biswas
Dipsikha Biswas
TPThomas Pulinilkunnil
Thomas Pulinilkunnil
GLGary D. Lopaschuk
Gary D. Lopaschuk

1 November 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Dipsikha BiswasDipsikha Biswas
Dipsikha Biswas
KDKhoi T. Dao
Khoi T. Dao
AMAngella Mercer
Angella Mercer
ACAndrew M. Cowie
Andrew M. Cowie
LDLuke Duffley
Luke Duffley
Dr. Thomas PulinilkunnilDr. Thomas Pulinilkunnil
Dr. Thomas Pulinilkunnil
Branched-chain α-keto acids (BCKAs) are catabolites of branched-chain amino acids (BCAAs). Intracellular BCKAs is cleared by branched-chain ketoacid dehydrogenase (BCKDH), which is sensitive to inhibitory phosphorylation by BCKD kinase (BCKDK). Accumulation of BCKAs is an indicator of defective BCAA catabolism and has been correlated with glucose intolerance and cardiac dysfunction. However, it is unclear whether BCKAs directly alter insulin signaling and function in the skeletal and cardiac muscle cell. Furthermore, the role of excess fatty acids (FA) in perturbing BCAA catabolism and BCKA availability merits investigation. By using immunoblot and UPLC MS/MS to analyze the hearts of fasted mice, we observed decreased BCAA catabolizing enzyme expression and increased circulating BCKAs, but not BCAAs. In mice subjected to diet-induced obesity (DIO), we observed similar increases in circulating BCKAs with concomitant changes in BCAA catabolizing enzyme expression only in the skeletal muscle. Effects of DIO were recapitulated by simulating lipotoxicity in skeletal muscle cells treated with saturated FA, palmitate. Exposure of muscle cells to high concentrations of BCKAs resulted in inhibition of insulin-induced AKT phosphorylation, decreased glucose uptake and mitochondrial oxygen consumption. Altering intracellular clearance of BCKAs by genetic modulation of BCKDK and BCKDHA expression showed similar effects on AKT phosphorylation. BCKAs increased protein translation and mTORC1 activation. Pretreating cells with mTORC1 inhibitor rapamycin restored BCKAs effect on insulin-induced AKT phosphorylation. This study provides evidence for FA mediated regulation of BCAA catabolizing enzymes, BCKA content and highlights the biological role of BCKAs in regulating muscle insulin signaling and function.

7 September 2015 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
MKMw Khan
Mw Khan
Dipsikha BiswasDipsikha Biswas
Dipsikha Biswas
MGM Ghosh
M Ghosh
SMS Mandloi
S Mandloi
SCS Chakrabarti
S Chakrabarti
PCP Chakrabarti
P Chakrabarti
For rapid tumor growth, cancer cells often reprogram the cellular metabolic processes to obtain enhanced anabolic precursors and energy. The molecular changes of such metabolic rewiring are far from established. Here we explored the role of mTOR (mechanistic target of rapamycin), which serves as a key regulator of cell growth, proliferation and survival, in the metabolic reprograming of cancer cells. When we inhibited mTOR in human hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC) cells, using pharmacologic inhibitors or by RNA interference, we noticed shuttle of the glycolytic flux to gluconeogenesis pathway along with reduction in cellular proliferation and survival. Augmentation of gluconeogenesis was mechanistically linked to upregulation of the key gluconeogenic enzymes PCK1 and G6PC expressions, enhanced lactate dehydrogenase activity and glucose-derived lipogenesis without causing any attenuation in mitochondrial function. Interestingly, concomitant knocking down of PCK1 and not G6PC along with mTOR pathway could overcome the inhibition of cancer cell proliferation and survival. These observations were validated by identifying distinctive diminution of PCK1 and G6PC expressions in human HCC and RCC transcriptome data. Significant correlation between mTOR-dependent upregulation of PCK1 and cell death in different cancer cell lines further emphasizes the physiological relevance of this pathway. We reveal for the first time that inhibition of mTORC2 and consequent redistribution of glycolytic flux can have a prosurvival role in HCC and RCC cancer cells only in the presence of downregulation of gluconeogenesis pathway genes, thus identifying novel pivots of cancer cell metabolic rewiring and targets for therapy.

1 October 2018 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
KDKenneth D'Souza
Kenneth D'Souza
CNCarine Nzirorera
Carine Nzirorera
ACAndrew M. Cowie
Andrew M. Cowie
GVGeena P. Varghese
Geena P. Varghese
PTPurvi Trivedi
Purvi Trivedi
Petra KienesbergerPetra Kienesberger
Petra Kienesberger
Kenneth D’Souza, Carine Nzirorera, Andrew M. Cowie, Geena P. Varghese, Purvi Trivedi, Thomas O. Eichmann, Dipsikha Biswas, Mohamed Touaibia, Andrew J. Morris, Vassilis Aidinis, Daniel A. Kane, Thomas Pulinilkunnil, Petra C. Kienesberger

2 August 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Dipsikha BiswasDipsikha Biswas
Dipsikha Biswas
MGMainak Ghosh
Mainak Ghosh
SKSubhankar Kumar
Subhankar Kumar
PCPartha Chakrabarti
Partha Chakrabarti
Adipose triglyceride lipase (ATGL) maintains an optimum mitochondrial function putatively by generating cognate ligands for peroxisome proliferator‐activated receptor α (PPARα), which, together with PPARγ coactivator‐1α (PGC1α), regulate muscle mitochondrial biogenesis. However, the cross‐talk between ATGL and PPARα in skeletal muscle mitochondrial metabolism and its implication in chronological aging is poorly understood. The role of ATGL in muscle mitochondrial metabolism was studied by overexpressing and depleting the geneandstudyingitsdownstreameffect in cultured myotubes and in murine skeletal muscle. We found that PPARα directly induces ATGL expression during myogenesis. Overexpression of ATGL significantly enhanced while depletion of ATGL attenuated mitochondrial oxidative phosphorylation and fatty acid oxidation without alteration in mitochondrial content, and it rendered PPARα and PGC1α redundant in promoting mitochondrial oxidative function. However, ATGL did not alter PPAR‐dependent lipid accumulation and insulin sensitivity. In middleaged rats, ATGL expression was higher and correlated with PPARα expression and sustained fatty acid oxidation in oxidative soleus muscle. Fenofibrate feeding further induced ATGL expression selectively in this muscle compartment. These findings illustrate that PPARα and ATGL constitute a regulatory pathway in skeletal muscle, suggesting their role as a mitochondrial metabolic reserve.—Biswas, D., Ghosh, M., Kumar, S., Chakrabarti, P. PPARα‐ATGL pathway improves muscle mitochondrial metabolism: implication in aging. FASEB J. 30, 3822–3834 (2016) www.fasebj.org